Mangalam Organics Limited

rs,

140 Date: August 09, 2025 BSE Limited Listing & Compliance Department Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai – 400001. Scrip Code: 514418 The National Stock Exchange of India Limi

10,000 MT

angalam Organics Ltd. got listed on NSE Successfully completed the expansion to manufacture 10,000 MT of Camphor 7 Our Business Segments B2B - Terpene Camphor: Religious use, healthcare products,

96%

2B Revenue break-up of Mangalam Organics Limited Business-to-Business Terpene Synthetic Resin 96% Terpene Operations 4% Synthetic Resin Operations Camphor| Dipentene | Sodium Acetate Terpen

4%

ngalam Organics Limited Business-to-Business Terpene Synthetic Resin 96% Terpene Operations 4% Synthetic Resin Operations Camphor| Dipentene | Sodium Acetate Terpene Phenolic Resin | Alkyl

rs 10

ns Camphor| Dipentene | Sodium Acetate Terpene Phenolic Resin | Alkyl Phenolic Resin | Rosin Esters 10 Our Product Portfolio – B2C Business-to-Consumer CamPure - Homecare and personal care products bas

7.39%

Retail Operations 12 Financials FY25 Consolidated Financial Performance Revenues (Rs. Crs) +7.39% 530.01 493.52 EBITDA (Rs. Crs) + 51.49 % 58.58 38.67 PAT (Rs. Crs) +196.91% 12.50 4.21 F

51.49 %

Consolidated Financial Performance Revenues (Rs. Crs) +7.39% 530.01 493.52 EBITDA (Rs. Crs) + 51.49 % 58.58 38.67 PAT (Rs. Crs) +196.91% 12.50 4.21 FY25 FY24 FY25 FY24 FY25 FY24 EBITDA Mar

196.91%

enues (Rs. Crs) +7.39% 530.01 493.52 EBITDA (Rs. Crs) + 51.49 % 58.58 38.67 PAT (Rs. Crs) +196.91% 12.50 4.21 FY25 FY24 FY25 FY24 FY25 FY24 EBITDA Margin (%) +321 bps 11.05% 7.84% FY25

321 bps

8.67 PAT (Rs. Crs) +196.91% 12.50 4.21 FY25 FY24 FY25 FY24 FY25 FY24 EBITDA Margin (%) +321 bps 11.05% 7.84% FY25 FY24 PAT Margin (%) + 151 bps • Revenue growth of 7.39 % in FY25 vs FY24

11.05%

(Rs. Crs) +196.91% 12.50 4.21 FY25 FY24 FY25 FY24 FY25 FY24 EBITDA Margin (%) +321 bps 11.05% 7.84% FY25 FY24 PAT Margin (%) + 151 bps • Revenue growth of 7.39 % in FY25 vs FY24. • Dec

7.84%

s) +196.91% 12.50 4.21 FY25 FY24 FY25 FY24 FY25 FY24 EBITDA Margin (%) +321 bps 11.05% 7.84% FY25 FY24 PAT Margin (%) + 151 bps • Revenue growth of 7.39 % in FY25 vs FY24. • Decrease

151 bps

FY25 FY24 FY25 FY24 EBITDA Margin (%) +321 bps 11.05% 7.84% FY25 FY24 PAT Margin (%) + 151 bps • Revenue growth of 7.39 % in FY25 vs FY24. • Decrease in profitability for the year. input